Article Cited by others

INVITED REVIEW

Selective androgen receptor modulators for the treatment of late onset male hypogonadism

Coss Christopher C, Jones Amanda, Hancock Michael L, Steiner Mitchell S, Dalton James T

Year : 2014| Volume: 16| Issue : 2 | Page no: 256-261

   This article has been cited by
 
1 A selective androgen receptor modulator SARM-2f activates androgen receptor, increases lean body mass, and suppresses blood lipid levels in cynomolgus monkeys
Megumi Morimoto,Masuo Yamaoka,Takahito Hara
Pharmacology Research & Perspectives. 2020; 8(1)
[Pubmed]  [Google Scholar] [DOI]
2 Overcoming resistance to anabolic SARM therapy in experimental cancer cachexia with an HDAC inhibitor
Sophia G Liva,Yu-Chou Tseng,Anees M Dauki,Michael G Sovic,Trang Vu,Sally E Henderson,Yi-Chiu Kuo,Jason A Benedict,Xiaoli Zhang,Bryan C Remaily,Samuel K Kulp,Moray Campbell,Tanios Bekaii-Saab,Mitchell A Phelps,Ching-Shih Chen,Christopher C Coss
EMBO Molecular Medicine. 2020;
[Pubmed]  [Google Scholar] [DOI]
3 Enclomiphene citrate: A treatment that maintains fertility in men with secondary hypogonadism
Joshua A Earl,Edward D Kim
Expert Review of Endocrinology & Metabolism. 2019; 14(3): 157
[Pubmed]  [Google Scholar] [DOI]
4 International Clinical Practice Guidelines for Sarcopenia (ICFSR): Screening, Diagnosis and Management
Elsa Dent,J. E. Morley,A. J. Cruz-Jentoft,H. Arai,S. B. Kritchevsky,J. Guralnik,J. M. Bauer,M. Pahor,B. C. Clark,M. Cesari,J. Ruiz,C. C. Sieber,M. Aubertin-Leheudre,D. L. Waters,R. Visvanathan,F. Landi,D. T. Villareal,R. Fielding,C. W. Won,O. Theou,F. C. Martin,B. Dong,J. Woo,L. Flicker,L. Ferrucci,R. A. Merchant,L. Cao,T. Cederholm,S. M. L. Ribeiro,L. Rodríguez-Mañas,S. D. Anker,J. Lundy,L. M. Gutiérrez Robledo,I. Bautmans,I. Aprahamian,J. M. G. A. Schols,M. Izquierdo,B. Vellas
The journal of nutrition, health & aging. 2018;
[Pubmed]  [Google Scholar] [DOI]
5 Detection of SARMs in doping control analysis
Mario Thevis,Wilhelm Schänzer
Molecular and Cellular Endocrinology. 2017;
[Pubmed]  [Google Scholar] [DOI]
6 Mass spectrometric characterization of the selective androgen receptor modulator (SARM) YK-11 for doping control purposes
Mario Thevis,Thomas Piper,Josef Dib,Andreas Lagojda,Dirk Kühne,Lars Packschies,Hans Geyer,Wilhelm Schänzer
Rapid Communications in Mass Spectrometry. 2017; 31(14): 1175
[Pubmed]  [Google Scholar] [DOI]
7 Enclomiphene citrate for the treatment of secondary male hypogonadism
Katherine M. Rodriguez,Alexander W. Pastuszak,Larry I. Lipshultz
Expert Opinion on Pharmacotherapy. 2016; : 1
[Pubmed]  [Google Scholar] [DOI]
8 Phase II drugs currently being investigated for the treatment of hypogonadism
Emeka Udedibia,Jed Kaminetsky
Expert Opinion on Investigational Drugs. 2014; : 1
[Pubmed]  [Google Scholar] [DOI]

 

Read this article